Maynard Um
-
-
-
-
-
-
-
Citi Starts BridgeBio Pharma (BBIO) at Neutral
-
-
-
-
-
-
-
BridgeBio gets Brazil approval for ATTR-CM heart drug acoramidis
-
-
-
-
-
-
-
RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
-
-
-
-
-
-
-
BridgeBio's acoramidis reduces mortality risk in heart disease patients
-
-
-
-
-
-
-
William Blair Starts BridgeBio Pharma (BBIO) at Outperform
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)
-
414,989 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

